Projects funded by the NCN

Combined targeted therapy with the use of PPAR receptor ligands or statins and cytostatics aimed at molecular mechanisms...

Call: SONATA 1 , Panel: NZ4

Principal investigator: dr Wojciech Placha

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Lekarski

Combined stem cell-based and gene therapy as a novel strategy to protect photoreceptors - evaluation of renewal mechanis...

Call: OPUS 4 , Panel: NZ5

Principal investigator: prof. Bogusław Machaliński

Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarski z Oddziałem Nauczania w Języku Angielskim

Natural and synthetic isothiocyanates as a compounds with potential anticancer activity

Call: PRELUDIUM 1 , Panel: NZ4

Principal investigator: Mateusz Psurski

Politechnika Wrocławska, Wydział Chemiczny

The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance...

Call: PRELUDIUM 3 , Panel: NZ5

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

Impact of combined therapy of non-steroidal anti-inflammatory drugs and selective serotonin reuptake inhibitors on oxida...

Call: OPUS 3 , Panel: NZ5

Principal investigator: dr hab. Piotr Gałecki

Uniwersytet Medyczny w Łodzi, Wydział Wojskowo-Lekarski, Klinika Psychiatrii Dorosłych

Combined induction of cell death of canine leukemia and lymphoma.

Call: OPUS 2 , Panel: NZ5

Principal investigator: dr hab. Andrzej Rapak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

Unlocking nature's potential - exploring the ability of newly isolated from the environment bacteriophage and its enzyme...

Call: PRELUDIUM 22 , Panel: NZ9

Principal investigator: Aleksandra Łukasiak

Uniwersytet Gdański, Wydział Biologii

Hybrid Nanocomposites Based on Gold Nanoparticles as Promising Photoactive Materials for Combined Photothermal/Photodyna...

Call: SONATINA 7 , Panel: ST4

Principal investigator: dr Paulina Błaszkiewicz

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum NanoBioMedyczne

Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st...

Call: SONATA 17 , Panel: NZ7

Principal investigator: dr Bartłomiej Pochwat

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

Call: OPUS 19 , Panel: NZ7

Principal investigator: dr hab. Janusz Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

Call: OPUS 16 , Panel: NZ5

Principal investigator: dr hab. Ryszard Smolarczyk

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach

Genetically modified dendritic cells as a component of combined therapy immunomodulating the tumor microenvironment

Call: OPUS 14 , Panel: NZ6

Principal investigator: dr hab. Elżbieta Pajtasz-Piasecka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Co-delivery drug systems based on ionic graft polymers carrying pharmaceutical anions with antibacterial activities for ...

Call: OPUS 14 , Panel: ST5

Principal investigator: prof. Dorota Neugebauer

Politechnika Śląska, Wydział Chemiczny

New amide derivatives of cinnamic acid as a carbonyl reductase inhibitors, which modulate the activity of doxorubicin - ...

Call: SONATA 11 , Panel: NZ7

Principal investigator: dr Paulina Koczurkiewicz-Adamczyk

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

System engineering approach to modeling, analysis and prediction of outcome of combined anticancer therapies

Call: OPUS 11 , Panel: ST7

Principal investigator: prof. Andrzej Świerniak

Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

Characterization and improvement of anti-cancer properties of second generation antagonists of Mdm2 oncoprotein

Call: SONATA 11 , Panel: NZ7

Principal investigator: dr Łukasz Skalniak

Uniwersytet Jagielloński, Wydział Chemii

New, multifunctional nanoparticles for combined photothermal and gene silencing cancer therapy

Call: OPUS 11 , Panel: ST8

Principal investigator: prof. Stefan Jurga

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Nanobiomedyczne

Phytoecdysteroids as a potential drugs inhibiting Toxoplasma gondii invasion

Call: OPUS 1 , Panel: NZ6

Principal investigator: dr Katarzyna Dzitko

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska